Oncopeptides AB (publ) (LON:0RN4)
1.700
-0.102 (-5.66%)
At close: May 30, 2025
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 28.96 million as of June 2, 2025. Its market cap has decreased by -45.03% in one year.
Market Cap
28.96M
Enterprise Value
30.96M
Revenue
3.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.70
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 149.07M to 28.96M, a decrease of -80.57%. That is a compound annual growth rate of -17.97%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 166.23B |
HSBC Holdings | 152.16B |
Shell | 145.59B |
Unilever | 117.27B |
Rio Tinto Group | 75.14B |
RELX PLC | 73.33B |
British American Tobacco p.l.c. | 73.04B |
Rolls-Royce Holdings | 72.41B |